Fig. 5
From: Potent anti-tumor immunostimulatory biocompatible nanohydrogel made from DNA
The assessment on the therapeutic effect of immunostimulatory CpG-RCA gel (R12) and CpG-MCA gels (R4M4 and R4M8) on cancer cells in vitro by plate clone formation assay. U251 cells treated with a none, b RAW264.7 cells, c RAW264.7 cells treated with CpG-ODN, d RAW264.7 cells treated with R12, e RAW264.7 cells treated with R4M4, and f RAW264.7 cells treated with R4M8. g Results of the proliferation percentage of U251 cells after co-cultured with RAW264.7 cells for 24 h. Results are expressed as the mean ± SD of three independent experiments. **P < 0.01, ***P < 0.001